Manager of the Finsbury Growth and Income trust Nick Train has increased his position in Fever-Tree, despite the soft drinks manufacturer delivering the worst performance across the portfolio in July.
In the latest monthly report, Train revealed he had bought more shares in the beverage producer after they fell 12% on a profit warning related to transportation and glass costs ahead of its H1 results. Nick Train uses DMGT cash to top up Fever-Tree and Experian The manager said he is confident about the company's secular growth opportunity in all its markets, especially in the US, and applauded management for "doing the right thing for the business". "It would be quite wrong for the company to protect its profit margins in current circumstances," he said. Such measures could incl...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
